Anti-Amyloid Imaging Abnormality in the Era of Anti-Amyloid Beta Monoclonal Antibodies: Recent Updates for the Radiologist

Anti-Amyloid Imaging Abnormality in the Era of Anti-Amyloid Beta Monoclonal Antibodies: Recent Updates for the Radiologist

Lecanemab and donanemab have received full U.S. Food and Drug Administration (FDA) approval, and subsequently, lecanemab has been approved by the Korean FDA and it has recently entered commercial use in Korea. This has increased interest in anti-amyloid immunotherapy for Alzheimer’s disease. Anti...

Full description

Saved in:
Bibliographic Details
Main Authors: So Yeong Jeong, Chong Hyun Suh, Jae-Sung Lim, Yangsean Choi, Ho Sung Kim, Sang Joon Kim, Jae-Hong Lee
Format: Article
Language:English
Published: The Korean Society of Radiology 2025-01-01
Series:Journal of the Korean Society of Radiology
Subjects:
alzheimer disease
dementia
immunotherapy
Online Access:https://doi.org/10.3348/jksr.2024.0140
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items